177 related articles for article (PubMed ID: 34906694)
1. Trace concentrations, heavy implications: Influences of biometals on major brain pathologies of Alzheimer's disease.
Lippi SLP; Neely CLC; Amaya AL
Int J Biochem Cell Biol; 2022 Feb; 143():106136. PubMed ID: 34906694
[TBL] [Abstract][Full Text] [Related]
2. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
Richey PL; Siedlak SL; Smith MA; Perry G
Biochem Biophys Res Commun; 1995 Mar; 208(2):657-63. PubMed ID: 7695621
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
5. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
6. Biological Signatures of Alzheimer's Disease.
Sharma P; Sharma A; Fayaz F; Wakode S; Pottoo FH
Curr Top Med Chem; 2020; 20(9):770-781. PubMed ID: 32108008
[TBL] [Abstract][Full Text] [Related]
7. Cellular cholesterol homeostasis and Alzheimer's disease.
Chang TY; Yamauchi Y; Hasan MT; Chang C
J Lipid Res; 2017 Dec; 58(12):2239-2254. PubMed ID: 28298292
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of Alzheimer's disease.
Gooch MD; Stennett DJ
Am J Health Syst Pharm; 1996 Jul; 53(13):1545-57; quiz 1603-4. PubMed ID: 8809275
[TBL] [Abstract][Full Text] [Related]
9. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
10. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
11. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
12. Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease.
Amponsah AE; Feng B; Guo R; Zhang W; He J; Kong D; Dong T; Ma J; Cui H
Rev Neurosci; 2020 Aug; 31(6):589-603. PubMed ID: 32364519
[TBL] [Abstract][Full Text] [Related]
13. An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease.
Menta BW; Swerdlow RH
Neurochem Res; 2019 Jan; 44(1):12-21. PubMed ID: 30084096
[TBL] [Abstract][Full Text] [Related]
14. [Apolipoprotein E4 and late-onset Alzheimer's disease].
Tamaoka A
Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
[TBL] [Abstract][Full Text] [Related]
15. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
Tran HT; LaFerla FM; Holtzman DM; Brody DL
J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
[TBL] [Abstract][Full Text] [Related]
16. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
17. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.
Yu L; Boyle PA; Leurgans S; Schneider JA; Bennett DA
Neurobiol Aging; 2014 Apr; 35(4):819-26. PubMed ID: 24199961
[TBL] [Abstract][Full Text] [Related]
18. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
Price KA; Crouch PJ; White AR
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
